DAVIE; Rebecca Louise
Patent Applications and Registrations
Patent applications and USPTO patent grants for DAVIE; Rebecca Louise.The latest application filed is for "enzyme inhibitors".
- DAVIE; Rebecca Louise - Salisbury GB
- DAVIE; Rebecca Louise - Porton Down GB
- DAVIE; Rebecca Louise - Wiltshire GB
| Patent | Date |
|---|---|
| Enzyme Inhibitors App 20220298138 - DAVIE; Rebecca Louise ; et al. | 2022-09-22 |
| Enzyme Inhibitors App 20220298141 - DAVIE; Rebecca Louise ; et al. | 2022-09-22 |
| Enzyme Inhibitors App 20220289727 - CHILDS; Mitchell Lewis ; et al. | 2022-09-15 |
| N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors App 20220289729 - Davie; Rebecca Louise ; et al. | 2022-09-15 |
| Enzyme Inhibitors App 20220048894 - DAVIE; Rebecca Louise ; et al. | 2022-02-17 |
| Enzyme Inhibitors App 20220002275 - Davie; Rebecca Louise ; et al. | 2022-01-06 |
| N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors Grant 11,198,691 - Davie , et al. December 14, 2 | 2021-12-14 |
| Pyrazole derivatives as plasma kallikrein inhibitors Grant 11,180,484 - Davie , et al. November 23, 2 | 2021-11-23 |
| N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors Grant 11,084,809 - Davie , et al. August 10, 2 | 2021-08-10 |
| N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors Grant 11,001,578 - Davie , et al. May 11, 2 | 2021-05-11 |
| N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors App 20200361923 - Davie; Rebecca Louise ; et al. | 2020-11-19 |
| N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors Grant 10,781,181 - Evans , et al. Sept | 2020-09-22 |
| N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors App 20200199116 - Davie; Rebecca Louise ; et al. | 2020-06-25 |
| N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors Grant 10,611,758 - Davie , et al. | 2020-04-07 |
| N-((het)arylmethyl)-heteroaryl-carboxamides Compounds As Kallikrein Inhibitors App 20190330200 - Davie; Rebecca Louise ; et al. | 2019-10-31 |
| N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Plasma Kallikrein Inhibitors App 20190300517 - Davie; Rebecca Louise ; et al. | 2019-10-03 |
| N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors Grant 10,364,238 - Davie , et al. | 2019-07-30 |
| Pyrazole Derivatives As Plasma Kallikrein Inhibitors App 20190218205 - DAVIE; Rebecca Louise ; et al. | 2019-07-18 |
| N-((het) Arylmethyl)-heteroaryl-carboxamides Compounds As Plasma Kallikrein Inhibitors App 20180319782 - DAVIE; Rebecca Louise ; et al. | 2018-11-08 |
| Benzylamine derivatives Grant 9,834,513 - Allan , et al. December 5, 2 | 2017-12-05 |
| N-((het) Arylmethyl)-heteroaryl-carboxamides Compounds As Plasma Kallikrein Inhibitors App 20170305863 - EVANS; David Michael ; et al. | 2017-10-26 |
| Benzylamine Derivatives App 20170253561 - Allan; Christine Elizabeth ; et al. | 2017-09-07 |
| Bicyclic inhibitors Grant 9,738,641 - Edwards , et al. August 22, 2 | 2017-08-22 |
| Benzylamine derivatives Grant 9,670,157 - Allan , et al. June 6, 2 | 2017-06-06 |
| Heterocyclic derivates Grant 9,533,987 - Davie , et al. January 3, 2 | 2017-01-03 |
| Bicyclic Inhibitors App 20160185773 - EDWARDS; Hannah Joy ; et al. | 2016-06-30 |
| Heterocyclic Derivates App 20160108036 - DAVIE; Rebecca Louise ; et al. | 2016-04-21 |
| Benzylamine Derivatives App 20160039752 - ALLAN; Christine Elizabeth ; et al. | 2016-02-11 |
| Benzylamine derivatives as inhibitors of plasma kallikrein Grant 9,234,000 - Evans , et al. January 12, 2 | 2016-01-12 |
| Benzylamine Derivatives As Inhibitors Of Plasma Kallikrein App 20150225450 - EVANS; DAVID MICHAEL ; et al. | 2015-08-13 |
| Benzylamine derivatives as inhibitors of plasma kallikrein Grant 9,051,249 - Evans , et al. June 9, 2 | 2015-06-09 |
| Benzylamine Derivatives As Inhibitors Of Plasma Kallikrein App 20140213611 - Evans; David Michael ; et al. | 2014-07-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 